Trials / Completed
CompletedNCT03103074
Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa
Randomized Double Blind Placebo Controlled Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University Hospital of North Norway · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Randomized double blind placebo controlled pilot study/proof of concept-study to see if intradermal injection with Botulinum toxin B is an effective treatment of Hidradenitis suppurativa
Detailed description
Twenty patients with hidradenitis suppurativa will be enrolled and randomised to treatment with either botulinum toxin B or placebo (saline) in affected areas. Intervention and recording of data will be performed every three months. After three months, all patients will receive active substance. After six months, randomization will revealed. Patients with clinical improvement will be given the opportunity to continue treatment for additional six months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botulinum B Toxin | Intradermal injections |
| OTHER | Placebo Saline | Intradermal injections |
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2018-03-23
- Completion
- 2018-09-23
- First posted
- 2017-04-06
- Last updated
- 2018-10-25
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT03103074. Inclusion in this directory is not an endorsement.